Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chalazion × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 411 Rectal Neoplasms 232 Colonic Neoplasms 188 Stomach Neoplasms 162 Pancreatic Neoplasms 158 Esophageal Neoplasms 117 Neoplasm Metastasis 101 Breast Neoplasms 101 Head and Neck Neoplasms 80 Squamous Cell Carcinoma of Head and Neck 75 Neoplasms 73 Adenocarcinoma Of Esophagus 58 Esophageal Squamous Cell Carcinoma 48 Carcinoma, Hepatocellular 45 Adenocarcinoma 36 Nasopharyngeal Carcinoma 29 Cholangiocarcinoma 28 Gastrointestinal Neoplasms 22 Anus Neoplasms 22 Keratosis, Actinic 21 Carcinoma, Non-Small-Cell Lung 21 Biliary Tract Neoplasms 21 Carcinoma, Squamous Cell 20 Gallbladder Neoplasms 19 Urinary Bladder Neoplasms 18 Liver Neoplasms 18 Bile Duct Neoplasms 18 Parkinson Disease 4, Autosomal Dominant Lewy Body 16 Nasopharyngeal Neoplasms 14 Unspecified Adult Solid Tumor, Protocol Specific 12

Interventions

Conservative Treatment 3 Probiotics 2 Curettage 2 tyramine-deoxysorbitol 1 Triamcinolone Acetonide 1 Triamcinolone 1 Tetracycline 1 Loteprednol Etabonate 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡